Delivery Order 36C25223D0046-36C25223N0320
Award Date 3/1/23
Potential Completion Date 2/28/25
Potential Value $608K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed price purchase order awarded to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7). The contract, valued at $440,764.00, is for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate to support nuclear medicine diagnostic services at VA medical centers. The award is designated as a total...
- This is a $1,415,722.03 firm fixed price contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine operations at VA medical facilities. RLS USA Inc. has received numerous federal contracts from VA and the Defense Health Agency to supply medical isotopes such...
- The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed price delivery order contract to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of non-pet radiopharmaceuticals. The contract, valued at $232,388.97, has an ultimate completion date of March 31, 2025. RLS (USA) Inc. is a small business that specializes in providing a range of medical isotopes and radiopharmaceutical products to support nuclear medicine diagnostic services at VA medical centers...
- This firm-fixed-price delivery order contract was awarded to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17. The contract is for the provision of radiopharmaceuticals, including gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate, which are critical for nuclear medicine imaging procedures and diagnostic services provided to veterans and military...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to RLS USA Inc., a foreign-owned, for-profit radiopharmacy, to provide various radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and other medical isotopes. The contract has a total potential value of $2,930,951.59 and includes a base year plus four one-year option periods, with deliveries to the VA Long Beach Healthcare System. The...
- This federal contract award is to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate. The contract, valued at $216,261.99, is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). RLS (USA) Inc. operates 31 radiopharmacy facilities across 18...
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the supply of radiopharmaceuticals and related services. The $878,999.37 firm-fixed price contract is not set aside and has an ultimate completion date of September 17, 2024. RLS (USA) Inc. specializes in providing a wide range of molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear medicine...
- The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a delivery order valued at $320,306.45 to RLS (USA) Inc. for the supply of radiopharmaceuticals. The contract, which was awarded on December 12, 2025, with an ultimate completion date of December 11, 2026, utilizes firm fixed price pricing and carries no set-aside designation. Performance will be conducted at RLS (USA) Inc.'s facility in Lake Mary, Florida. This delivery order falls under a larger indefinite...
- This is a $425,725.07 firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the supply of non-pet radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. It has a performance period from April 1, 2025 to March 31, 2026. The contract is not a set-aside. RLS (USA) Inc. is a small business that specializes in providing...
- This is a federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, by the Department of Veterans Affairs (VA). The contract is for the supply of critical radiopharmaceuticals used in nuclear medicine diagnostic services at VA medical centers and military treatment facilities. The contract has a ceiling value of $315,075.54 and is a firm fixed-price purchase order with a performance period ending on February 28, 2026. RLS (USA) Inc. is a small business that...